GoHealth, Inc. (GOCO) 股票分析

公司概述

GoHealth, Inc. operates as a prominent health insurance marketplace and a Medicare-focused digital health company within the United States, offering a comprehensive suite of plans including Medicare Advantage, Medicare supplement, prescription drug plans, and special needs plans. The company functions within the Financial Services sector, specifically categorized under the Insurance Brokers industry, positioning it as a key intermediary in the distribution of health coverage. In terms of scale, the entity reports a market capitalization of $30.29M, generates annual revenue of $361.84M, and employs 850 individuals. These valuation and revenue figures suggest that the company operates with a significantly constrained market cap relative to its reported revenue stream, indicating a specific market position or structural characteristics distinct from large-cap peers where market capitalization typically aligns more closely with revenue multiples.

财务健康

The company reports a trailing twelve-month revenue of $361.84M, a net income of -$261,050,000, and an EBITDA of -$79,834,000. The substantial gap between the positive revenue figure and the deeply negative net income reveals a cost structure where expenses, likely driven by acquisition costs, underwriting losses, or operational overhead, vastly exceed the gross profit generated from premiums. Free cash flow stands at -$113,457,504, which indicates that the company is currently burning cash rather than generating liquidity, thereby limiting its financial flexibility for debt repayment, share buybacks, or significant capital expenditures without external financing. The margin profile presents a gross margin of 73.4%, which suggests high revenue retention after direct costs, contrasted sharply by an operating margin of -252.9% and a profit margin of -71.1%. These negative operating and profit margins indicate that overhead expenses and general administrative costs are so elevated that they consume the entire gross profit and then some, resulting in a bottom line that is severely depressed relative to sales. On the balance sheet, the company holds $32.90M in cash against $672.59M in debt, a disparity that highlights a highly leveraged position, while the debt-to-equity ratio is listed as N/A, further obscuring the traditional leverage metrics due to the equity erosion. The current ratio is 2.02, which theoretically indicates a conservative stance on short-term liquidity as current assets are twice the value of current liabilities, yet this metric must be viewed in the context of the massive absolute debt load. Return on Equity is -219.7% and Return on Assets is -7.7%, metrics that reveal management is currently destroying shareholder value and utilizing assets inefficiently to generate profits, as returns are deeply negative across both equity and asset bases.

估值评估

The valuation metrics show a trailing P/E ratio of N/A due to negative earnings, while the forward P/E is -0.27, implying that the market expects earnings to remain negative in the immediate future or that the current pricing does not reflect a return on earnings yet. The price-to-book ratio is 0.45, indicating that the stock trades at less than half its book value, which often suggests a market discount reflecting the company's poor profitability or high perceived risk. Alternative valuation metrics include a price-to-sales ratio of 0.08 and an EV/EBITDA of -7.68, suggesting that the market is pricing the company based on minimal sales multiples rather than earnings power, a common trait for distressed or turnaround candidates with negative cash flows. The 52-week high is $11.36 and the low is $1.00; without a specific current price provided in the facts, the valuation sits within a range where the stock has demonstrated extreme volatility, having fallen from a high of $11.36 to a low of $1.00 over the last year. The beta value is 1.60, meaning the stock's price volatility is significantly higher than the broader market, moving 60% more than the market index on average, which introduces substantial risk for risk-averse investors.

Growth & Income

Revenue growth year-over-year is -96.8%, while earnings growth is N/A due to the absence of positive comparable earnings figures. The decline in revenue indicates a contraction in the business model or a loss of market share, and since earnings are already negative, the concept of earnings growing faster or slower than revenue is moot in the traditional sense, but the revenue contraction is a primary driver of the financial deterioration. As a non-dividend payer with a dividend yield of N/A and a payout ratio of 0.0%, the company does not distribute cash to shareholders, effectively reinvesting its limited resources into operations or retaining cash to service its massive debt obligations. The overall growth and income profile is characterized by severe revenue contraction, negative earnings, and a lack of dividend income, presenting a high-risk scenario where the primary focus must be on stabilizing the revenue stream to address the significant debt burden.